Raising Funds for Growth Investments through Stock Acquisition Rights Issued by Third-Party Allotment
First written in FY2018-Q3. 1 of 3 entries say "Advanced", first in FY2018. Latest entry: FY2020-Q3.
4 other companies' latest entry also says "Other".
- FY2020-Q3Acquisition and cancellation of the 2nd Series 2 Stock Acquisition RightsAnnual report
「On 25 November 2019, we acquired and cancelled all 1,000,000 shares of the company's common stock underlying the "2nd Series of Stock Acquisition Rights with Adjustment Provisions for the Exercise Price Issued through a Third-Party Allotment" issued on 15 December 2017.」
All stock acquisition rights in the 2nd Series then outstanding, representing 1,000,000 underlying common shares, were acquired and cancelled on 25 November 2019. - FY2018AdvancedAnnual report
「As part of these efforts, we issued stock acquisition rights with adjustment provisions for the exercise price through a third-party allotment to raise funds for securing and developing human resources, developing new products and services leveraging our 3 existing businesses, and pursuing M&A and capital and business alliances. Exercise of the 1st Series was completed during the fiscal year.」
The company raised funds through stock acquisition rights issued by third-party allotment. Exercise of the 1st Series was completed during the fiscal year, resulting in annual funding of ¥1,006 million. - FY2018-Q3First statedAnnual report
「As part of these efforts, we issued new share acquisition rights through a third-party allotment, with provisions for adjustment of the exercise price, to raise funds for securing and developing personnel, developing new products and services based on our 3 existing businesses, and pursuing M&A and capital and business alliances.」
The company issued stock acquisition rights through a third-party allotment to secure and develop human resources, develop new products and services, and pursue M&A and capital and business alliances. The filing states that the 1st and 2nd series totaled 22,000 rights, representing 2,200,000 underlying shares, with an exercise period from 18 December 2017 to 17 December 2019.